Berkshire Hathaway Sells $69 Million of DaVita Stock
Berkshire Hathaway sold 382,563 shares of DaVita for $69.0 million, trimming its stake in the kidney care provider, according to a Form 4 filed with the Securities and Exchange Commission on Thursday.
The sale took place on Tuesday, Oct. 27, at a weighted average price of $180.4305 a share, the filing showed. Berkshire reports as a holder of more than 10% of DaVita's stock, and Warren Buffett is listed alongside Berkshire as a reporting person.
What Berkshire still owns
After the sale, the reported holdings stood at 28,314,666 DaVita shares. The shares sold represent 1.33% of the 28,697,229 shares reported before the transaction.
According to footnotes in the filing, 13,341,058 of the remaining shares are owned by Government Employees Insurance Company, the Berkshire subsidiary better known as GEICO. Another 14,973,608 shares are held by pension plans of Berkshire subsidiaries: 4,441,520 by the BNSF Master Retirement Trust and 10,532,088 by the Berkshire Hathaway Inc. Consolidated Pension Plan. Berkshire, Buffett and those pension plans disclaim beneficial ownership of the pension shares, the filing said.
The filing does not identify the buyer of the shares, and the sale was not marked as made under a Rule 10b5-1 trading plan.
By the numbers
- 382,563: DaVita shares sold
- $180.4305: weighted average sale price
- $69,026,033: total proceeds
- 28,314,666: shares reported after the sale
- 13,341,058: shares owned by GEICO
Sources
- Form 4 filed by Berkshire Hathaway Inc. and Warren E. Buffett for DaVita Inc., filed Oct. 29, 2026 (accession 0001193125-26-438090)
This article is for informational and educational purposes only and is not investment advice. It is not a recommendation to buy or sell any security.
Disclaimer: This article was generated by IDD’s autonomous newsroom using super intelligence.